STOP T1D

06/05/2026

New in : A Dutch study found that young people managing feel burdened by treatments and their day-to-day health management responsibilities. Here are some key takeaways from their research report:

"Young adults with type 1 diabetes experience substantial treatment burden, particularly for daily care tasks, and report moderate health-related quality of life, with emotional well-being and daily functioning most affected."

"Higher treatment burden and lower HRQoL may be associated with female gender, lower time in range and dissatisfaction with diabetes management approach."

"Tailoring care plans and supporting shared decision making may help reduce treatment burden and better align diabetes management with young adults' daily lives and personal priorities."

Diabetic Medicine | Diabetes UK Journal | Wiley Online Library https://onlinelibrary.wiley.com/doi/10.1111/dme.70376

06/04/2026

New in : Danish study concludes that "both type 1 diabetes (T1D) and type 2 diabetes (T2D)... were associated with a higher incidence of subtrochanteric or femoral shaft (ST or FS) and hip fractures."

"Overall, ST or FS fractures were reported in 1.9% of patients with T1D and 11.9% of those with T2D, whereas hip fractures were reported in 1.7% and 11.4% of patients with T1D and T2D, respectively"

https://www.medscape.com/viewarticle/danish-study-links-type-1-diabetes-femoral-fractures-2026a1000ibx

Both T1D and T2D are linked to a higher incidence of subtrochanteric or femoral shaft and hip fractures, but after adjusting for age, only the association for T1D remains significant.

06/03/2026

New out of Japan: Family members of people who screened positive or are currently managing should also be screened for the autoantibodies. The more you know, the better informed and prepared you can be!

The first epidemiological study of presymptomatic type 1 diabetes among first-degree relatives in Japan: PREP-T1D study https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(26)00270-6/fulltext

Autoimmune type 1 diabetes (T1D) is characterized by an immune-mediated loss of β-cell function due to the activation of an autoimmune pathological process over time, and islet autoantibodies (IAbs) are known as key markers for the diagnosis of T1D [1].

06/01/2026

We are certainly in favor of routine, early screenings beginning for pediatric patients as young as age 1, and beyond!

"Findings from this pilot offer critical insights into the practical implementation of presymptomatic type 1 diabetes screening and monitoring programs in diverse clinical environments. Despite identified barriers, continuous quality improvement efforts, along with identified facilitators to success, led to an increase in the number of individuals screened and monitored. Future work will focus on expanding these efforts across diverse care settings, with strategies to support sustainability beyond pilot phases."

To find a T1D screening program (many are no cost) visit our colleagues at ASKhealth.org

Read: "Bringing early detection to life: real-world operationalization of a presymptomatic type 1 diabetes screening and monitoring pilot program" > https://drc.bmj.com/content/14/3/e005980

05/29/2026

Check out these useful tips from Breakthrough T1D on getting through summer heat and activities while managing !

How to Prepare and Plan for Summer Emergencies with T1D - Breakthrough T1D https://www.breakthrought1d.org/news-and-updates/type-1-diabetes-t1d-hurricanes-wildfires-heat-waves-power-outages-emergencies/

Depending on where you live, common summer emergency situations may include heat waves, hurricanes, wildfires, and power outages.

05/26/2026

What is Type 1 Diabetes?

Type 1 diabetes (T1D) is an autoimmune disease — that means your immune system is attacking your own body.

is a condition that can affect anyone, no matter their age or family history. By getting screened for T1D-related autoantibodies, you can find out if you are more likely to develop T1D. T1D screenings are available for children too.

Visit ASKhealth.org to find a no cost T1D and disease screening program for children over 1 year, teens, and adults.

Being aware that you are at high risk for T1D enables you to recognize symptoms early, participate in T1D prevention research trials, and explore therapy options to postpone the onset of clinical T1D.

Learn more: STOPT1Dprogram.org

source: https://medschool.cuanschutz.edu/barbara-davis-center-for-diabetes/patient-care/early-t1d-clinic

05/21/2026

New in : "Global obesity rates have risen sharply in recent years, driving higher cardiometabolic morbidity and mortality. This troubling trend has affected people with type 1 diabetes as well. Beyond total body adiposity, fat distribution is critical for health, because central obesity is strongly linked to cardiometabolic conditions." Insulin resistance and inflammation are contributing factors.

Waist-to-Height Ratio Is Associated With the Risk of Coronary Artery Disease in Type 1 Diabetes: A 19-Year Cohort Study https://diabetesjournals.org/care/article/49/6/1095/164748/Waist-to-Height-Ratio-Is-Associated-With-the-Risk

Obesity, kidney disease, and coronary artery disease (CAD) are interconnected. Here, the relationship between central obesity and CAD across albuminuria ca

05/19/2026

Breakthrough T1D funded a research study to determine the cost effectiveness and efficacy of treatment and intervention clusters for people who otherwise have access to few diabetes management resources and interventions.

The research revealed that "mobile health interventions show cost-effectiveness across income settings where supporting infrastructure exists. Intervention clusters provide greater health impact but require higher investment. These findings support evidence-based resource allocation considering both cost-effectiveness and local implementation capacity."

Type 1 diabetes intervention clusters in resource-limited settings: a systematic review and economic evaluation https://www.sciencedirect.com/science/article/abs/pii/S2213858726000021

05/18/2026

We're all getting ready for the American Diabetes' Association's 86th Scientific Sessions, taking place in New Orleans June 5-8, 2026. The latest will be shared by experts from around the world. See you there!

ADA's 86th Scientific Sessions are coming up https://www.breakthrought1d.org/news-and-updates/its-that-time-of-year-adas-86th-scientific-sessions-are-coming-up/

Register for the conference and learn more here: https://professional.diabetes.org/scientific-sessions

Breakthrough T1D is attending the 2026 ADA conference in New Orleans, LA from June 5-8 to discuss cutting-edge type 1 diabetes updates.

05/12/2026

🗓️ HCPs - Mark your calendars!

9th Symposium on General Population Screening for T1D
November 9-10, 2026

Save the date for the 9th Symposium on General Population Screening for T1D, on November 9-10, 2026, in Denver, Colorado. It will be accessible in person at the Anschutz Health Sciences Building or as a hybrid meeting.

The symposium aims to explore the expanding evidence and current international efforts to identify pre-symptomatic T1D, emphasizing the potential benefits such as delayed progression and prevention of complications. Through expert panels and case studies, the event will also address the challenges of screening, monitoring and supporting children with early-stage T1D. The discussions will conclude with future directions for screening, highlighting the need for coordinated efforts and policy guidance.

TARGET AUDIENCE:
Healthcare professionals including MD, DO, nurses, social workers, and dieticians; researchers in the area of screening, monitoring, and prevention of diabetes; lay representatives of patient organizations and representatives of funding agencies.

Contact [email protected] for any questions about this event. Registration link will be shared soon!